We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-21.50 | -1.58% | 1,340.00 | 1,338.50 | 1,339.50 | 1,368.00 | 1,337.50 | 1,363.50 | 3,512,318 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.26 | 56.44B |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2009 14:45 | Swine flu claims another victim. | montyhedge | |
30/4/2009 14:43 | bluepill, Sounds good but is it a bluechip multinational with the diversity of revenue streams, paying a healthy dividend? NO. Pure speculation. People are in GSK for the company as a whole, not just because of the current H1N1 virus outbreak. | oilgetmecoat | |
30/4/2009 14:42 | If this goes to Level 6, add £15 billion to revenue. | montyhedge | |
30/4/2009 14:41 | GSK Relanza cost £40 retail, South Korea as doubled supplies of Relanza, GSK to make a fortune. | montyhedge | |
30/4/2009 14:37 | forget gsk, puricore is the best play at the moment. active sterilization agent effective against swineflu | bluepill | |
30/4/2009 14:35 | Second retest of £10-50 underway. I suspect it will prove as support once more. I suggest to get out of your short as a good price soon Lord Luc4n. Good luck | oilgetmecoat | |
30/4/2009 14:03 | I get my tenner soon | lord luc4n | |
30/4/2009 13:52 | Should be way over 1125p, broker new BUY said 1389p without swine flu. | montyhedge | |
30/4/2009 13:45 | Moving higher now - may see £11 today. | sat69 | |
30/4/2009 11:57 | So far, so good. Textbook stuff. Consolidating £10-50 as support. Blah blah....who's still short?? | oilgetmecoat | |
30/4/2009 11:29 | Great Q1 results from AZN giving GSK a little help this morning. | sailing john | |
30/4/2009 11:09 | First pullback and test of £10-50 underway....lets see if it holds. A couple more restests and then off we go higher... | oilgetmecoat | |
30/4/2009 10:53 | Ok, one must endure another 19 holes, keep feeding this pig chaps as one has green fees to pay! | lord luc4n | |
30/4/2009 10:53 | Thanks for explaining WongaUK. I feel sorry for those shorting GSK, probably at levels below £10 thinking this was going to plummet to new lows not seen in over 5 years!! Amazing. Short from the top, not the bottom you FOOLS! | oilgetmecoat | |
30/4/2009 10:51 | oilgetmecoat - Just ignore the mentally deficient. | wongauk | |
30/4/2009 10:26 | donaceace....explain | oilgetmecoat | |
30/4/2009 10:19 | I rest my case. Stated here quite clearly to you LL. £10-55 now broken, at some point we will see retrace to prove as support....if it holds a few times we move support level up from £10-30. Blah blah...simple stuff really. I ask LL to clarify why he is shorting against all the odds?? | oilgetmecoat | |
30/4/2009 10:14 | 1st resistance level IMO = £3 | donaceace | |
30/4/2009 10:13 | LL....do you think £1-55 will be resistance this time (going for it for the third time today as we speak)?? My guess is it will brush thru', then retest to prove as support a few times over next few days, before progressing higher. Simple resistance becomes support stuff,,,blah, blah... | oilgetmecoat | |
30/4/2009 09:56 | oilgetmecoat - Absolutely ;-) | wongauk | |
30/4/2009 08:58 | This is simple support and resistance movement now....£10-30 new support, retested a few times now. Under that, £10. For sure. However, not much resistance that I can see on the way up....a few like £10-50, £10-85....but not strong. Hence the risk reward ration for this share is great. Get in. | oilgetmecoat | |
30/4/2009 08:53 | UK Gov currently hold 33m doses of Tamiflu & Relenza. This covers 50% of population. They have announced this will go up to 80% with an extra 17m doses now on order. I expect 7m of those to be Relenza. If we assume other countries will be doing the same - as the WHO has urged them to - the only problem for GSK is keeping up with demand. If you hold, sit tight as its going get interesting. | acumen | |
30/4/2009 08:39 | Should see my 10 Quid soon | lord luc4n |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions